Streetbeat News

Regulatory

XTLB

XTL Biopharmaceuticals has received a notification from Nasdaq regarding a minimum bid price deficiency. The company's shares have been trading below the minimum $1.00 per share requirement for continued listing.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 8:02 pm

SPY

Kevin McCarthy, a prominent figure in US politics, has endorsed Tom Emmer for Speaker, stating that Emmer is the right person for the job and understands the dynamics of the conference. This news was reported by Punchbowl's Jake Sherman.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 7:53 pm

PFE

The U.S. Food and Drug Administration (FDA) has approved Pfizer's PENBRAYA, a vaccine for the prevention of the five most common serogroups causing meningococcal disease in adolescents. The vaccine provides the broadest serogroup coverage of any meningococcal vaccine available in the U.S. and could simplify the complex vaccination schedule. The approval is based on data from Phase 2 and Phase 3 trials, demonstrating robust immunogenicity and a favorable safety profile.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 7:36 pm

EIS

SPY

President Biden had a discussion with Prime Minister Benjamin Netanyahu of Israel on Friday. The conversation included plans to start moving humanitarian assistance into Gaza from Egypt, following up from the President's visit to Israel.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 7:32 pm

JAZZ

Denmark's medical cannabis pilot trial has seen a 90% growth in patient enrollment over 12 months, making it the largest access scheme in the country. The Pilot Programme allows all doctors to prescribe any unlicensed medicines approved for trial. Jazz Pharmaceuticals' (NASDAQ:JAZZ) Sativex and Epidoloex are only allowed under the Pharmaceutical Scheme. In other news, Malta's Sprawt Chra violated advertising rules, Ireland's College of General Practitioners issued a statement opposing cannabis legalization, and Swiss public health professionals visited a Barcelona cannabis social club to exchange harm reduction strategies.

Portfolio Pulse from Nina Zdinjak

October 20, 2023 | 7:19 pm

TSNDF

The New Jersey Cannabis Regulatory Commission (NJ-CRC) has approved 112 adult-use cannabis licenses, expanding the state's cannabis industry. Meanwhile, TerrAscend Corp. (OTCQX:TSNDF) has faced scrutiny for violating medical cannabis rules in New Jersey. The company has submitted a corrective action plan, but a subsequent violation occurred. The NJ-CRC has decided not to recommend a fine in this instance.

Portfolio Pulse from Joana Scopel

October 20, 2023 | 7:11 pm

SPY

GOP Rep Bergman has announced his intention to run for Speaker. This political development could potentially influence the broader market, as represented by SPY.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 7:00 pm

SPY

U.S. House Republicans are set to weigh Speaker candidates at 6:30 p.m. ET on Monday, with a vote scheduled for Tuesday morning, according to Representative Andy Barr.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 6:15 pm